Related Experiment Video
Updated: Apr 30, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Patient genotypes impact survival after surgery for isolated congenital heart disease
Daniel Seung Kim1, Jerry H Kim2, Amber A Burt3
1Department of Medicine, Division of Medical Genetics, University of Washington School of Medicine, Seattle, Washington; Department of Genome Sciences, University of Washington School of Medicine, Seattle, Washington.
Insights
Genetic variations in vascular endothelial growth factor A and superoxide dismutase 2 influence survival after infant cardiac surgery. Infants with high-risk alleles face a significantly increased risk of death or heart transplant.
Area of Science:
- Cardiovascular Surgery
- Genetics
- Pediatrics
Background:
- Infant survival post-cardiac surgery depends on oxidative stress and vascular regulation.
- Genetic variations in these pathways may impact outcomes in congenital heart disease.
Purpose of the Study:
- To investigate the association between genetic variations in oxidative stress and vascular response pathways and postoperative survival.
- To test the hypothesis that genetic polymorphisms influence survival in infants with nonsyndromic congenital heart disease.
Main Methods:
- Analysis of a cohort of 422 infants undergoing cardiac surgery before 6 months of age.
- Genotyping of six single nucleotide polymorphisms (SNPs) in key genes.
- Cox proportional hazard models used to assess effects on transplant-free survival, adjusting for covariates.
Main Results:
- Specific SNPs in vascular endothelial growth factor A (rs833069) and superoxide dismutase 2 (rs2758331) were significantly associated with long-term survival.
- A cumulative risk score based on these SNPs demonstrated an additive effect, with higher scores correlating with worse transplant-free survival.
- Patients with the highest risk score (4 risk alleles) had a 15.64-fold increased hazard for adverse outcomes.
Conclusions:
- Genetic variants in VEGFA and SOD2 are significant modifiers of survival after infant cardiac surgery.
- Infants homozygous for high-risk alleles in both genes face a substantially elevated risk of death or heart transplant.
- These findings highlight the role of genetic predisposition in surgical outcomes for congenital heart disease.
Background:
Survival after cardiac surgery in infancy requires adaptive responses from oxidative stress management and vascular regulation pathways. We tested the hypothesis that genetic variation in these pathways influences postoperative survival in nonsyndromic congenital heart disease children.
Methods:
This is an analysis of a cohort of nonsyndromic congenital heart disease patients who underwent cardiac surgery with cardiopulmonary bypass before 6 months of age (n=422). Six single nucleotide polymorphisms (SNPs) in six genes involved in oxidative stress and vascular response pathways, identified through a priori literature search, were tested for effects on transplant-free survival. Survival curves, adjusting for confounding covariates, were calculated using the Cox proportional hazard models.
Results:
Long-term survival was strongly associated with vascular endothelial growth factor A gene SNP rs833069 (p=7.03×10(-4)) and superoxide dismutase 2 gene SNP rs2758331 (p=0.019). To test for joint effects of the two SNPs on transplant-free survival, the genotypes were grouped to form a risk score reflecting the cumulative number of risk alleles (0 to 4 alleles per patient). A higher risk score based on the VEGFA and SOD2 SNP genotypes was associated with worse transplant-free survival (p=3.02×10(-4)) after confounder adjustment. The total burden of risk alleles was additive; subjects with the highest risk score of 4 (n=59 subjects, 14.2% of the cohort) had a total covariate-adjusted hazard ratio of 15.64 for worse transplant-free survival.
Conclusions:
After cardiac surgery, infants who are homozygous for the high-risk alleles for both the VEGFA and SOD2 SNPs have an approximately 16-fold increased risk of death or heart transplant, suggesting that genetic variants are important modifiers of survival after surgery for congenital heart disease.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pharmacogenomics: Identification of New Drug Targets

